Biomarker for Metachromatic Leukodystrophy (BioMeta) Disease
NCT01536327 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2023-02-13
Summary
Development of a new MS-based biomarker for the early and sensitive diagnosis of Metachromatic Leu-kodystrophy disease from blood (plasma)
Conditions
- Peripheral Neuropathy
- Muscle Weakness
Sponsors & Collaborators
-
CENTOGENE GmbH Rostock
lead INDUSTRY
Principal Investigators
-
Peter Bauer, Prof. · Centogene GmbH
Eligibility
- Min Age
- 1 Day
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-08-20
- Primary Completion
- 2021-02-28
- Completion
- 2021-02-28
Countries
- Egypt
- Germany
- India
- Sri Lanka
Study Locations
More Related Trials
-
Identification of Novel Biomarkers in Early Charcot-Marie-Tooth 1A Disease
NCT07049588 ·Status: RECRUITING ·Phase: NA
-
Gut Microbiota in Patients With Moyamoya Disease
NCT04890782 ·Status: UNKNOWN
-
Development and Validation of a Disability Severity Index for CMT
NCT01455623 ·Status: COMPLETED
-
Collection of Samples and Clinical Data From Patients With Amyloid Diseases
NCT00898235 ·Status: RECRUITING
-
Muscle MRI in Charcot Mary Tooth Disease: a Prospective Cohort Study
NCT03550300 ·Status: UNKNOWN
-
Acute Infection in Mitochondrial Disease: Metabolism, Infection and Immunity
NCT04419870 ·Status: RECRUITING
-
Neurometabolic Profile of Individuals With Primary Mitochondrial Disease
NCT06890520 ·Status: RECRUITING
-
Screening for Monoclonal Gammopathy in Individuals Undergoing Physical Examinations Using iMS-LC Assay Technology.
NCT06489613 ·Status: NOT_YET_RECRUITING
-
Development and Validation of Multi-nuclear Magnetic Resonance Imaging and Spectroscopy for Whole Body Human Applications
NCT02663362 ·Status: RECRUITING
-
Application of Biomarkers in Neurological Diseases
NCT05881226 ·Status: RECRUITING
-
Metabolomic Exploration of Dysregulated Lipid Metabolism in MFN2-related CMT2A (MetaDLM_CMT2A)
NCT04881201 ·Status: COMPLETED ·Phase: NA
-
COVID-19 Infection and Multiple Myeloma
NCT04492371 ·Status: COMPLETED
-
Tools for Therapeutic Evaluation in Charcot-Marie-Tooth Disease Type 1A: Outcome Measures and Biomarkers
NCT02596191 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
GDF-15 as a Biomarker for Mitochondrial Disease
NCT02745938 ·Status: COMPLETED
-
A Registered Cohort Study on Charcot-Marie-Tooth Disease
NCT04010188 ·Status: RECRUITING
-
Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others
NCT01193075 ·Status: RECRUITING
-
the Study of the Association Between the Gut Microbiota and Central Serous Chorioretinopathy
NCT06527326 ·Status: RECRUITING ·Phase: NA
-
Clinical Database and Biobank of Patients With Inflammatory Myopathies: the MASC Project (Myositis, DNA, Serum, Cells) (MASC)
NCT04637672 ·Status: COMPLETED
-
Stellate Ganglion Block to Treat Long COVID 19 Case Series
NCT05812209 ·Status: COMPLETED
-
Connective Tissue Motion Measure
NCT01413997 ·Status: COMPLETED
-
MRS to Determine Neuroinflammation and Oxidative Stress in MPS I
NCT03576729 ·Status: COMPLETED
-
Natural History, Pathogenesis and Outcome of Melorheostosis A Rare Osteosclerotic Disease
NCT02504879 ·Status: RECRUITING
-
Follow-up of Patients With Inflammatory Myopathies Associated With a Biobank
NCT05454527 ·Status: RECRUITING
-
Transcriptomic Study of Adult Population With Marfan Syndrome
NCT05700175 ·Status: RECRUITING
-
Evaluate the Use of the Foundation Pain Index and the Nutritional Supplement BioPlete™ in Adults With Chronic Pain
NCT05278533 ·Status: COMPLETED ·Phase: NA